chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore injection site became red, itchy and raised one week after injection; Sore injection site became red, itchy and raised one week after injection; Sore injection site became red, itchy and raised one week after injection; Sore injection site became red, itchy and raised one week after injection; Lymph node on same arm became painful one week after; This is a spontaneous report from a non-contactable nurse, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 13Sep2021 at 10:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS) and known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metformin (MANUFACTURER UNKNOWN) and unspecified multivitamin; both taken for unknown indications from an unknown date and unknown if ongoing. On 21Sep2021 at 11:00, the patient had sore injection site became red, itchy and raised one week after injection. Also lymph node on same arm became painful one week after. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore injection site became red, itchy and raised one week after injection and lymph node on same arm became painful one week after was resolving at the time of report.  No follow-up attempts are possible. No further information is expected.
Child's adoptive mother reports on 9/9/04 that child is having "cluster seizures" since 7/23/04. Prior to vx, child was on Topamax 50 mg, increased to 75 mg. States previous last known seizure 3 yrs ago. States child has not seen MD, but reporting status by phone.
On March 3, 2021 at 1:45 PM, I received the first dose of Moderna COVID Vaccine (Lot: 027A21A) via IM injection on my left arm. On March 5, 2021 at approximately 11:45 PM, I had a gushing nose bleed (an event that is extremely rare for me). The bleeding  stopped after 35 minutes following pressure and ice.  On March 7, 2021 at approximately 1 PM, I had a gushing nose bleed. The bleeding stopped after 28 minutes following only pressure. On March 8, 2021 at approximately 1 PM, I had a nose bleed that lasted 17 minutes following only pressure.
nausea; vomiting; body aches; stomach ache; weakness; confusion; fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), VOMITING (vomiting), MYALGIA (body aches), ABDOMINAL PAIN UPPER (stomach ache) and ASTHENIA (weakness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced HEADACHE (Headache). On 01-May-2021, the patient experienced NAUSEA (nausea), VOMITING (vomiting), MYALGIA (body aches), ABDOMINAL PAIN UPPER (stomach ache), ASTHENIA (weakness), CONFUSIONAL STATE (confusion) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NAUSEA (nausea), VOMITING (vomiting), MYALGIA (body aches), ABDOMINAL PAIN UPPER (stomach ache), ASTHENIA (weakness), CONFUSIONAL STATE (confusion), PYREXIA (fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment details was Tylenol every 4-6 hours pertained to the events experienced.
MIGRAINE; SORE ARM; HEADACHE; FATIGUE; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: unknown) dose, one total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced migraine, sore arm, headache, and fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sore arm, headache, migraine and fatigue was not reported. This report was non-serious.
Complaint of dizziness and appeared pale.  Pt was in observation area outdoors. Mask removed; ammonia inhalant waved under nose. BP taken while reading 97/58. Pt was laid down on cot with legs elevated. Pt reported feeling better and dizziness resolved. Pt stated that the only thing he consumed was a milkshake. Pt was given water, juice and crackers. Pt also reported history of fainting after a blood draw.  Second BP was 112/78.  Nursing staff counselled pt. to eat breakfast and drink plenty of fluids prior to 2nd COVID vaccine. Pt remained in observation area for 30 minutes. Pt?s color returned and reported feeling well and was observed to ambulate with steady gait to his car.
11-17-16 Pt. developed hives approximately 6-7 hours after receiving the KINRIX vaccine. Hives were on her arms, trunk, legs. Recommended BENADRYL PO. 11-18-16 Hives were not present in the morning, but developed late morning on arms, face - milder case. 11-21-17 Hives on face very few. Getting milder each day.
got it and then got shingles/suspected vaccination failure; shingles; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient specified that the vaccine apparently did not work. The patient got the Shingles shot and then got the shingles. The physician said that well they found out that vaccine did not work and seems like the patient should had been notify by somebody. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
No additional AE details provided; Improperly stored Proquad administered; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information about pertinent medical history, drug reaction/allergy, and concomitant medication was not provided.  On 16-AUG-2021, the patient was vaccinated with improperly stored dose of measles, mumps, rubella, and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (lot #T029103 was confirmed to be valid, expiration date 23-FEB-2022; dose, route of administration, and anatomical location were not reported) for prophylaxis. The storage temperature was 9.6 Celsius degrees for 80 minutes. There was no previous temperature excursion. No additional adverse event details provided (no adverse event).  This is one of several reports received from the same reporter. Sender's Comments:  US-009507513-2108USA006155: US-009507513-2108USA006146: US-009507513-2108USA006125: US-009507513-2108USA005918: US-009507513-2108USA006030:
I was diagnosed with breast cancer in the left. I noticed a lump in my left breast. They gave mammogram and they didn't see anything suspicious. I had an Ultrasound on April 29, 2022, and they found a hypoechoic mass in the left breast. In October they recommended that I come in for a biopsy on October 24. They diagnosed me with Ductal carcinoma in situ. I have a tumor in my left breast. I am still in the mist of treatment. I am scheduled for a mastectomy on December 06, 2022. I have to meet with a doctor post treatment to see if I need chemo. I had another ultrasound on April 29, 2022 and found that the mass had grown. I also had an MRI on November 3rd. They confirmed Malignancy of the tumor in my left breast. I started health therapist also and. I have also seen a genetic counselor. I will see an oncologist next week.
Brought in by Mom on 102616 and received MENACTRA and VARIVAX without difficulty. Mom calls 120516 and reports daughter is pregnant. Has had 4 positive pregnancy tests at home. States LMP around 102616. Missed period in November. Has not seen MD yet. WIC apt tomorrow 120616, will do preg. test.
Pt recv vax on 12/7/98; on 1/11/99 pt exp rash (5-6 spots)
Weakness, fall, fatigue Narrative:  Patient received his second COVID vaccine. He was experiencing weakness, fever, myalgia and general fatigue. He fell at home and went into the ER. He received liter of LR in the ER and was discharged home. He was to continue to take acetaminophen for fever and myalgias.
The patient, , arrived to the vaccinator table without guardian or teacher present. Parental consent and screening completed prior to patient?s arrival to vaccination site. Department of Health () staff member sat down next to child, due to child appearing anxious about vaccination. Both the vaccinator and staff member noted that child appeared nervous about vaccination and was crying lightly prior to vaccination but trying to hold in tears. Child was vaccinated successfully, and immediately following vaccination, child began crying more significantly. Within approximately 30 seconds, staff member and vaccinator noted localized erythema on right side of child?s neck. staff called over RN for further assessment of child. Upon RN assessment, RN also noted localized erythema on right side of child?s neck. No erythema was noted on torso or appendages. Patient denied experiencing any itchiness. No lip, tongue, or facial swelling was present. No signs of respiratory distress were present. Child stated that he felt ?fine,? but was nervous that so many people were surrounding him. RN sat with child for 15 minutes at vaccination table, with no worsening of localized erythema and no other symptoms noted in that time period. After 15 minutes, care was relinquished to school RN, who continued to observe child for an additional 15 minutes. School RN took child to nurse?s office, away from stimulating vaccination environment. School RN noted that child?s localized erythema began to subside when child left the stimulating environment and entered the quiet space of the nurse?s office. School nurse observed child for 15 additional minutes (30 minutes total from vaccination) and noted that localized erythema had completely resolved after the 30 minutes from vaccination. School nurse contacted child?s guardian, and guardian was informed of incident. School nurse and guardian made decision that child could stay at school for the day. School nurse and RN concur that this occurrence was most likely a stress response to vaccination.
positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable unspecified HCP reporting for herself. This 61-year-old female patient received on 22Dec2020 BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. On 24Dec2020, the patient had a bad reaction, coughing, headache, no taste, tiredness and body aches. The patient thought originally, she was having a reaction to the vaccine, and took some ibuprofen (ADVIL). The patient was still congested and was sent for testing. She was tested positive on 28Dec2020. The test was a nasal swab. Outcome was unknown. The patient was wondering if this was part of the side of effect of the vaccine.  Information on the batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded.  The case will be reassessed if additional information becomes available.
Suspected vaccination failure; Shingles; Shingles; This case was reported by a consumer via media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure, ophthalmic herpes zoster and shingles were unknown.   It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster and shingles to be related to Shingles vaccine.  Additional details were provided as follows:  The age at vaccination was not reported.  The patient received Shingles vaccine and later got shingles, almost lost her eye sight. The reporter stated that dam if you do and dam if you dont. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation for shingles infection and time to event onset was unknown. This case has been linked with US2021AMR128529, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR128529:Same reporter. "a few people" master case.
Moderna COVID-19 Vaccine  Nausea, Diarrhea, Muscle Aches and Tightness, Fatigue, Flush/Low Grade Temperature, Pain in Neck and Joints
Patient is having severe pain in the arm since administration.  It hasn't gone away now 18 days later.  Administration site shows no sign of redness or swelling, but patient reports needed Ibuprofen everyday in order to function because of the pain.
ongoing repository Illness; still seeing a doctor for my sinus; bronchitis; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 23-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Jul2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 22 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LEXAPRO; ADDERALL; FAMODINE; NEXIUM 1-2-3. Past drug history included: Amoxicillin, reaction(s): "Known allergies: Amoxicillin", notes: Known allergies: Amoxicillin. Vaccination history included: Bnt162b2 (Dose 1, Batch/Lot No: Unknown, Location of injection: Arm Left), for Covid-19 immunization; Bnt162b2 (Dose 2, Batch/Lot No: Unknown, Location of injection: Arm Left), for COVID-19 immunization. The following information was reported: BRONCHITIS (hospitalization, life threatening) with onset 01Apr2022, outcome "not recovered"; RESPIRATORY DISORDER (hospitalization, life threatening) with onset 01Apr2022, outcome "not recovered", described as "ongoing repository Illness"; SINUS DISORDER (hospitalization, life threatening) with onset 01Apr2022, outcome "not recovered", described as "still seeing a doctor for my sinus". The patient was hospitalized for respiratory disorder, sinus disorder, bronchitis (hospitalization duration: 1 day(s)). The events "ongoing repository illness", "still seeing a doctor for my sinus" and "bronchitis" required physician office visit and emergency room visit. Patient had several hospitalizations occur due to bronchitis and she is a healthy 23-year-old. She have had ongoing repository Illness since early Apr2022 after her last Pfizer vaccination. Currently still seeing a doctor for her sinus and bronchial troubles (non smoker). The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (01Sep2022) Negative, notes: Nasal Swab. Therapeutic measures were not taken as a result of respiratory disorder, sinus disorder, bronchitis.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
From initial information received on 28Mar05 from a health care professional regarding an adverse event occurring, it was reported that an 18 year old female pt received a first dose of Menactra, lot number U1493AC, administered SC in error in her left arm on 23Mar05. One day later, on 24Mar05, the pt developed a local reaction of redness and swelling at the site of injection. She was seen in an ER on 26Mar05 and was treated with Clindamycin. She has recovered from these events. OMIC
Pt experienced left arm swelling and redness. Pt also experienced tenderness and warmth to touch following the 5th dose of the Anthrax vaccine.
1020 PATIENT HAS RED SPOTS ON ARMS AND SMALL AMOUNT ON CHEST. PATIENT DENIES SHORTNESS OF BREATH. COMPLAINS OF ITCHING. 1025 PATIENT TOOK BENADRYL 50MG PO. NO DIFFICULTY SWALLOWING. 1042 PATIENT STATES SHE FEELS BETTER, ITCHING HAS STOPPED. PATIENT STATES SHE IS READY TO GO HOME AND WILL FOLLOW UP WITH PRIMARY CARE PHYSICIAN
Approximately 12 hours after administration, dizzyness. Following morning, extreme dizzyness (room spinning) even while lying down. nauseous, vomiting, weakness. Continued for 3 days. Had virtual visit with PA-C. 2 prescriptions ordered. Meclizine and Ondansetron ODT. Condition somewhat improved but still 11 days later remaining unsteadiness and slightly dizzy
Cannot lift left arm past a certain point. The arm has constantly been sore for the past few weeks.
2/25/07 Sudden onset of headache and fever to 102-has appt to see Ped MD this am 2/26/07.  2/16/06 per mother, pt has strep throat after PMD visit.
Tuesday afternoon I started itching on the trunk of my body and upper thighs, and I also broke out with hives. I took BENADRYL and used hydrocortisone cream. I went to an urgent care where I was prescribed prednisone 20mg to take twice daily. By Thursday morning the hives got worse, I went in to see my PCP who sent me to a dermatologist. I was told to continue the prednisone and he added hydroxyzine and ZYRTEC three times a day. He also took two skin biopsies. The dermatologist felt this was viral, but he doesn't really know. I am finally feeling better.
05/31/2022 I began coughing and took a home COVID test that was negative. On 06/01/2022 I had aches, chills and was still coughing. My cough was like a postnasal drip, not a bad cough. That afternoon I had a fever that reached to 102 and felt like I had the flu. I felt crappy. I tested positive with a home COVID test. I went to a walk-in clinic on 6/3/2022 and had a positive COVID PCR test. I corresponded with my PCP.  My PCP offered PAXLOVID. I declined taking the PAXLOVID since my COVID symptoms were mild. I had also read about rebounds to PAXLOVID. I also read there might be a problem with the blood pressure medicine I was taking. My PCP told me rebound was possible. My PCP did not insist on me taking the PAXLOVID since my symptoms were mild. She told me if I experienced any respiratory issues or cardiac symptoms, I should get to the emergency room and I assured her I would do that. My recovery was gradual. I realized I was not aching as much. I had a productive cough like a post nasal cough. I tested positive on the 9th day, but by the 10th day I was negative on my home test. It took about another week for my stamina to get back. Today, I have my stamina back. I am very appreciative to Pfizer for their vaccine. I feel like my symptoms with COVID were not as bad thanks to my vaccine.
Patient developed redness on her arm the morning following the vaccine. Patient waited through the weekend and called physician's office on Monday 6/7/21 and was advised to go to the walk in clinic. Patient was seen by provider and was told cellulitis and given a 10 day course of augmentin 875mg.
Patient experienced Nausea and tingling sensation in the arm and Numbness in the arm and finger immediately after vaccination of Covid-19 Pfizer Vaccine. Patient was observed closely for 30 minutes and patient walked out of vaccine site  awake and oriented. Patient did not vomit after feeling nauseated .
From Patient: Reporting for awareness, I received a tdap shot from the wellness clinic on Tuesday. Wednesday - the area was swollen, red, burning, and painful. I called in this day and stayed home. Thursday -I came in to the office and the area had increased in size. I went to Urgent Care and they said it was infected and that the shot was given to low. I was prescribed antibiotics for the infection. I am working from home today.       Total Wellness: Dr.:  Doubt it was too low and even if it were - that would not cause infection.  More likely it is an inflammatory reaction from the shot itself.
Arthralgia FATIGUE, CHILLS, PAIN INJ SITE, SOB, RUNNY NOSE
In October I went to bathroom early in the morning. I looked at the looked clock it was 2am in the morning the next thing I know it is 4am in the morning. I don't remember anything. I went to the hospital, I had bruises on my stomach, under my chin, under my arm. It was very hard for me to get up. I had to pray and ask God to help me to get up. After three days in the hospital, I was released, my test came back showing nothing caused me to pass out. I have been to the chiropractor, pain specialist and primary care doctor. No one has been able to help me. I cannot turn my head to the right without it causing me a lot of pain. I can barely lift my hand halfway up my body.
Information has been received from a registered nurse concerning a 11 year old female who in approximately 2007 was vaccinated with a first dose of Gardasil.  It was reported that after the patient received her first dose of Gardasil she experienced nausea and vomiting the same day which continued the next day.  Unspecified medical attention was sought.  Subsequently, the patient recovered.  Additional information has been requested.
Painful, black discoloration of several of my toes. These appeared during the third week after the vaccination and lasted for approximately two weeks before dissipating and finally disappearing.
On 3/7 (Day 8), patient found a 2 inch diameter swelling at the injection that feels red, hot, warm, and itchy. There are small bumps on the skin. Previously there was no itch or swelling or discomfort in the days prior to the onset. (Patient remembers being able to finally sleep on her left side after the initial discomfort/swelling subsided). This is the first day of feeling these new symptoms and therefore the symptoms have not yet subsided.
Information has been received from a physician concerning a female 20 years of age or younger with no pertinent medical history who was vaccinated with Gardasil.  There was no concomitant medication.  Subsequently the patient experienced influenza-like symptoms (headache, some nausea, vomiting and myalgia) within 24 hours of receiving her first dose of Gardasil.  The patient possibly had a CPK level that was mildly elevated (values not provided).  The patient was possibly examined in the emergency room but was not admitted.  Subsequently, the patient's symptoms resolved within one to four days.  Unspecified medical attention was sought.  Patient Quality Complaints (PQC) was not involved.  This is one of several reports received from the same source.  Additional information has been requested.
Severe body aches, malaise, nausea, chills, rash on chest.